CA2623473A1 - Compositions and methods for detection of colorectal cancer - Google Patents

Compositions and methods for detection of colorectal cancer Download PDF

Info

Publication number
CA2623473A1
CA2623473A1 CA002623473A CA2623473A CA2623473A1 CA 2623473 A1 CA2623473 A1 CA 2623473A1 CA 002623473 A CA002623473 A CA 002623473A CA 2623473 A CA2623473 A CA 2623473A CA 2623473 A1 CA2623473 A1 CA 2623473A1
Authority
CA
Canada
Prior art keywords
ibabp
polypeptide
sample
polynucleotide
mrna
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002623473A
Other languages
English (en)
French (fr)
Inventor
Jeffrey W. Smith
Changming Fang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanford Burnham Prebys Medical Discovery Institute
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2623473A1 publication Critical patent/CA2623473A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Engineering & Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA002623473A 2005-09-21 2006-09-21 Compositions and methods for detection of colorectal cancer Abandoned CA2623473A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US71974705P 2005-09-21 2005-09-21
US60/719,747 2005-09-21
PCT/US2006/037103 WO2007058704A2 (en) 2005-09-21 2006-09-21 Compositions and methods for detection of colorectal cancer

Publications (1)

Publication Number Publication Date
CA2623473A1 true CA2623473A1 (en) 2007-05-24

Family

ID=38049100

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002623473A Abandoned CA2623473A1 (en) 2005-09-21 2006-09-21 Compositions and methods for detection of colorectal cancer

Country Status (5)

Country Link
US (2) US20090005307A1 (https=)
EP (1) EP1926836A4 (https=)
JP (1) JP2009523009A (https=)
CA (1) CA2623473A1 (https=)
WO (1) WO2007058704A2 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008088836A2 (en) * 2007-01-16 2008-07-24 The Burnham Institute For Medical Research Compositions and methods for treatment of colorectal cancer
US10166328B2 (en) * 2013-05-29 2019-01-01 Icu Medical, Inc. Infusion system which utilizes one or more sensors and additional information to make an air determination regarding the infusion system
AU2019284405B2 (en) * 2018-06-13 2025-08-21 Genex Health Co.,Ltd Colorectal cancer solid tumour primary cell and colorectal cancer ascitic fluid primary tumour cell culturing method, and matching reagent

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5541308A (en) * 1986-11-24 1996-07-30 Gen-Probe Incorporated Nucleic acid probes for detection and/or quantitation of non-viral organisms
US6974669B2 (en) * 2000-03-28 2005-12-13 Nanosphere, Inc. Bio-barcodes based on oligonucleotide-modified nanoparticles
PT1581812E (pt) * 2003-01-06 2008-09-22 Wyeth Corp Composições e métodos para diagnóstico e tratamento de cancros do cólon

Also Published As

Publication number Publication date
WO2007058704A2 (en) 2007-05-24
EP1926836A2 (en) 2008-06-04
WO2007058704A3 (en) 2009-05-28
JP2009523009A (ja) 2009-06-18
US20110200996A1 (en) 2011-08-18
EP1926836A4 (en) 2010-03-10
US20090005307A1 (en) 2009-01-01
US8563248B2 (en) 2013-10-22

Similar Documents

Publication Publication Date Title
JP6148007B2 (ja) 前立腺癌マーカーとしてのホスホジエステラーゼ４ｄ７
CA2767914C (en) Markers for endometrial cancer
KR101872965B1 (ko) Ｃ―ｍａｆ를 이용하는 전립선암 전이의 진단, 예후 및 치료 방법
WO2006105486A2 (en) Novel tumor suppressor gene and compositions and methods for making and using the same
CA2742641A1 (en) Compounds for immunotherapy of prostate cancer and methods for their use
JP2007114212A (ja) 前立腺ガンの免疫診断のための化合物およびそれらの使用方法
MX2014012233A (es) Metodo para prognosis y tratamiento de metastasis de cancer.
KR20160061424A (ko) 유방암으로부터 기원하는 골의 전이성 암의 예후 및 치료 방법
CN1942581B (zh) 针对破骨细胞相关蛋白质的抗体
EP1565582A2 (en) Methods for identifying risk of breast cancer and treatments thereof
US20090074785A1 (en) Compositions and methods for treatment of colorectal cancer
US8563248B2 (en) Compositions and methods for detection of colorectal cancer
WO2006078911A2 (en) Gitr antibodies for the diagnosis of nsclc
CN101087804B (zh) 用于诊断和治疗癌症的aimp2dx2的用途
JP2003525599A (ja) 肺癌特異的遺伝子による肺癌の診断、モニタリング、病期分類、イメージングおよび治療の方法
JP5923450B2 (ja) 癌に対する素因についてのマーカーとしてのｍｉｔｆ
CA2464700C (en) Ibc-1 (invasive breast cancer-1), a putative oncogene amplified in breast cancer
US20050118606A1 (en) Methods for identifying risk of breast cancer and treatments thereof
US20100120899A1 (en) Tumor Repressor Genes in the Prevention of Cancer
US20030064377A1 (en) Compositions and methods relating to prostate specific genes and proteins
JP6312861B2 (ja) がん発症の予測、早期診断、及び治療剤としてのｎｋｘ６．３の用途
US20050142572A1 (en) Compositions, splice variants and methods relating to lung specific nucleic acids and proteins
JP2004503602A (ja) フォスファトニン関連遺伝子およびその使用法
US20030039986A1 (en) Compositions and methods relating to prostate specific genes and proteins
WO2006078780A2 (en) Rdc1 antibodies for the diagnosis of nsclc

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued

Effective date: 20130923